Industry Focus
Healthcare: ASH 2017's Big Winners And Losers
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:28:35
- Mais informações
Informações:
Sinopse
Celgene and bluebird bio report a stunning success in multiple myeloma, Juno Therapeutics takes it on the chin despite positive data, and Spark Therapeutics suffers in its showdown with BioMarin in hemophilia.
